Related Experiment Videos

Nucleotide sequence of the Rasheed rat sarcoma virus oncogene: new mutations

Science (New York, N.Y.)
|July 8, 1983
PubMed

Insights

Researchers sequenced the rat sarcoma virus oncogene (Ra-v-ras), revealing a distinct 29,000-dalton transforming protein (p29). This protein differs from Harvey murine sarcoma virus p21, with unique amino and carboxyl terminus mutations specific to rat sarcoma virus.

Area of Science:

  • Molecular Biology
  • Virology
  • Oncology

Background:

  • The Rasheed strain of rat sarcoma virus contains an oncogene responsible for cellular transformation.
  • Understanding oncogene sequences is crucial for identifying viral oncogenes and their protein products.

Purpose of the Study:

  • To determine the nucleotide sequence of the rat sarcoma virus oncogene (Ra-v-ras).
  • To characterize the transforming protein encoded by Ra-v-ras and compare it to related viral proteins.

Main Methods:

  • Nucleotide sequencing of the Ra-v-ras oncogene.
  • Analysis of the encoded protein sequence and comparison with Harvey murine sarcoma virus p21.

Main Results:

  • The Ra-v-ras oncogene encodes a 29,000-dalton transforming protein (p29).
  • The p29 protein exhibits distinct amino-terminal sequences and additional carboxyl-terminal mutations compared to Harvey murine sarcoma virus p21.
  • These sequence variations appear to be unique to the rat sarcoma virus.

Conclusions:

  • The nucleotide sequence analysis reveals a novel transforming protein (p29) in the Rasheed rat sarcoma virus.
  • The identified sequence differences suggest potential functional or regulatory distinctions between rat sarcoma virus and Harvey murine sarcoma virus.
  • Further investigation is needed to elucidate the functional significance of these observed mutations in p29.

Related Concept Videos